UPDATE: Barclays Starts Legand Biotech Corp. (LEGN) at Overweight

March 15, 2022 6:39 AM EDT Send to a Friend
(Updated - March 15, 2022 6:40 AM EDT)

Barclays analyst Gena Wang initiates coverage on Legand Biotech Corp. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login